CD274 and neoplasm: Studies have reported that the predictive accuracy of PD-L1 expression improves when assessing the combined positive score (CPS), which evaluates PD-L1 on both tumor cells and infiltrating immune cells, rather than solely the tumor proportion score (TPS), which measures PD-L1 on tumor cells alone [11, 12].